Plasma Cell Neoplasms
📧 Sign up to get email alerts when something new happens for Plasma Cell Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 trial to assess safety and efficacy of HDP-101 in Chinese patients with relapsed or refractory multiple myeloma, currently recruit…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms [EARLY_Phase 1]
ClinicalTrials.gov entry for an early phase 1 study of CAR19BCMA CAR-T cells for relapsed or refractory plasma cell neoplasms. The trial is …
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Longitudinal Data Registry of Plasma Cell Dyscrasia
This entry describes a longitudinal data registry study of plasma cell dyscrasias, including multiple myeloma, sponsored by Shanghai Zhongsh…
-
CLINICAL_TRIALS research · 2010-01-28Clinical Trial Update: Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders [Phase 2]
A Phase 2 clinical trial update evaluating stem cell transplantation for hematological cancers or related disorders, listing conditions such…